Trump, White House demand FDA justify tough standards for vaccine, raising concerns of political interference

The White House’s involvement appears to go beyond the perfunctory review that agency officials had expected, and is likely to reinforce public concerns that a coronavirus vaccine may be rushed to benefit the president’s reelection campaign.